SWOG clinical trial number
SWOG-8940
A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer
Closed
Phase
Accrual
100%
Published
Abbreviated Title
A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer
Activated
03/01/1990
Closed
11/01/1992
Publication Information Expand/Collapse
1997
Phase 1 trial of recombinant human interleukin 1B (rhIL-1B), and etoposide in patients with solid cancers: Southwest Oncology Group study 8940